JAK2 and acquired polycythemia vera: This neoplasm is etiologically linked to a somatic mutation in the JAK2 gene (JAK2V617F), which is found in about 90% of patients with PV, and in about 50% of essential thrombocythemia (ET) and primary myelofibrosis (MF) [16].